Slingshot members are tracking this event:

Celgene's(CELG) OTEZLA in Behcet’s Disease PDUFA date expected July 21, 2019

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
CELG Community voting in process

Additional Information

Additional Relevant Details
FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Otezla, Behcet's Disease